Showing results (761-770 of 2,357) with videos related to
Sort By:
Pageof 236
Clinical Neuropharmacology|August 1, 1993
Symptomatic anti-parkinsonian effects of monoamine oxidase-B inhibition: comparison of selegiline and lazabemideP A LeWitt, S A Segel, K L Mistura, et al.Clinical Neuropharmacology|August 1, 1993
Complex hallucinatory state occurring postsurgery: a case reportC M FisherClinical Neuropharmacology|February 1, 1993
Is there a relationship between Parkinson's disease and essential tremor?R Pahwa, W C KollerClinical Neuropharmacology|February 1, 1993
Quantitative assessment of parkinsonian patients by continuous wrist activity monitoringJ J Van Hilten, G Hoogland, E A van der Velde, et al.Clinical Neuropharmacology|February 1, 1993
Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophyJ M Senard, O Rascol, G Durrieu, et al.Clinical Neuropharmacology|January 1, 1993
The advent of a new generation of monoamine oxidase inhibitor antidepressants: pharmacologic studies with moclobemide and brofaromineG Lavian, J P Finberg, M B YoudimClinical Neuropharmacology|January 1, 1993
Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studiesG Chouinard, B M Saxena, N P Nair, et al.Clinical Neuropharmacology|January 1, 1993
Pharmacology of moclobemideW Haefely, W P Burkard, A Cesura, et al.Clinical Neuropharmacology|January 1, 1983
Practical considerations in planning and conducting clinical trials with investigational or marketed drugsB SpilkerClinical Neuropharmacology|January 1, 1984
Biochemical characterization of 17 beta-hydroxysteroid dehydrogenase in human meningiomaP M Martin, A M Rieg, S Fournier, et al.Pageof 236